The IHH gene helps guide how cartilage turns into bone, especially in growing bones of the arms, legs, fingers, and toes. This gene plays an important role in normal bone length and shape during development. If it does not work as expected, bone growth can change, which may lead to short stature, shortened fingers or toes, or other differences in the skeleton.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes provide the code for proteins, the parts of cells that do much of the work. Others mainly help control when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
IHHGene function
What if the gene works
The IHH gene helps guide bone growth, especially in the arms, legs, hands, and feet. It also supports normal cartilage development and helps growing bones form in an organized way.
Risk
What if the gene does not work
Variants in the IHH gene can affect bone growth, often causing shortened fingers or toes and in more severe cases short stature with hip or limb changes. Milder and more severe variants can influence how noticeable these features are.
Treatment
What does that mean for your treatment
No treatment or drug choice linked specifically to a pathogenic variant in the IHH gene is currently established. Researchers are studying hedgehog signaling, including IHH-related pathways, as a possible drug target in some cancers and bone conditions, but this has not led to standard treatment for inherited IHH-related conditions.
Conditions associated with IHH
Gene function
What if the gene works
The IHH gene helps guide how bones form and grow, especially in the arms, legs, hands, and feet. It sends signals between cartilage, the firm flexible tissue near growing bones, and nearby bone forming cells. A central part of the IHH gene's role in bone growth is keeping these steps well timed during development and childhood growth.
The IHH gene helps control growth in the growth plate, the area near the ends of long bones where length is added. It tells cartilage cells when to keep dividing and when to begin maturing.
Its signal helps cartilage and bone development stay in step during endochondral ossification (the process where cartilage is gradually replaced by bone). This keeps new bone forming in the right place and at the right pace.
The IHH gene encourages nearby cells to become osteoblasts, the cells that make new bone tissue. This supports the hardening and shaping of developing bones.
Signals from the IHH gene help organize the shape of the skeleton during early development, including parts of the hands, feet, and joints. It supports clear boundaries between growing areas so bones form in an orderly layout.
What is a variant?
A genetic variant is a slight change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant affects how a gene works to a greater degree and may contribute to, or directly cause, a genetic condition.
Genetic variants
What if the gene does not work
How IHH gene variants affect bone development depends on how much they alter the shape, processing, or release of the signaling protein, leaving nearby cartilage cells with a weaker or altered message. Some variants only partly reduce signaling, while more disruptive variants can greatly limit protein stability or receptor binding. This range can help explain why IHH-related skeletal features, including short stature and finger or toe differences, are milder in some people and more marked or appear earlier in others.
How variants are linked to conditions
Variants in the IHH gene are linked to inherited skeletal conditions. Some pathogenic variants cause brachydactyly type A1, which leads to unusually short fingers or toes, while others can cause acrocapitofemoral dysplasia, a condition that affects bone growth in the hips, hands, and feet. These well-established conditions linked to variants in the IHH gene can vary in how strongly they affect height, joint shape, and everyday movement.
A variant is not necessarily a diagnosis
Variants in genes are a normal feature of human biology and are widespread in the general population. Most do not directly affect health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. In some situations, though, a single well understood variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the IHH gene. In families with an IHH change, the main factor is whether that change is present, while the way it shows up can vary from person to person.
Inheritance of IHH variants
The inheritance pattern for IHH-related conditions can differ depending on the specific condition and variant type. For families learning how variants of the IHH gene are inherited, some IHH gene changes linked to brachydactyly type A1 follow an autosomal dominant pattern, so a parent carrying the variant has a 50% chance of passing it to each child. Other IHH gene changes linked to acrocapitofemoral dysplasia follow an autosomal recessive pattern, which means a child usually inherits one altered copy from each parent. Boys and girls are affected at similar rates because the IHH gene is on chromosome 2, not a sex chromosome.
What does my IHH result mean for my family?
IHH results can have different family implications because this gene is linked to more than one inherited condition. For the more common hand and foot shortening pattern tied to IHH, close relatives such as a parent, brother, sister, or child may also carry the same change and may have similar features, even if these are mild. For the rarer recessive bone growth condition, relatives may be healthy carriers, and brothers or sisters may be more likely to share the condition than parents.
Genetic information
Genetic testing
How you find out about variants
IHH gene genetic testing usually uses a blood or saliva sample. A lab reads the DNA code in the IHH gene and looks for variants by sequencing, then compares what it finds with known, clinically described changes. Results may identify a variant linked to an IHH related condition, show no relevant variant, or find a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the IHH gene may be worth considering if you or a relative has a condition affecting bone growth, such as very short fingers or toes, short stature, or similar skeletal changes that run in the family. A result can help confirm whether an IHH change is the cause and clarify the chance of it affecting relatives.
A genetic result is only one part of your health story
A genetic result may offer important insight, but how much it can tell you depends on the condition and on the kind of variant involved. How the body works over time is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information gives context rather than certainty and is best considered with other parts of care. In other situations, the result may give a clear answer. In fields such as medication response, genetic results can also help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment, yet one may get the expected benefit while the other may have less effect or be more sensitive to side effects because their bodies absorb, break down, or respond to the drug differently. This kind of variation is common and is one reason medication response is not exactly the same for everyone.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how genetic differences affect response to medications. It examines relationships between genes and drugs to help explain why treatments can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This understanding can support more informed and more individualized treatment decisions. If you want to learn more about this topic, you can read more in the LearnHub.
Drugs influenced by the IHH gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so questions about symptoms, treatment, or possible side effects are best discussed with your doctor or pharmacist.
History
The IHH gene entered medical genetics in the 1990s, when researchers identified it as one of the human hedgehog genes after earlier work in fruit flies had revealed the broader hedgehog signaling pathway. Its name, Indian hedgehog, followed the naming style used for related genes discovered at the same time. From these first observations, research expanded steadily. Interest in the IHH gene grew as scientists linked changes in it to inherited patterns of short stature and unusual bone development seen across generations. This helped connect older clinical descriptions of family skeletal conditions with a specific genetic cause. Over time, these findings made the IHH gene an important part of the history of growth and bone genetics.